Literature DB >> 26382710

Hidradenitis suppurativa: a review with a focus on treatment data.

D Barlev1, D B Eisen2, A Alikhan1.   

Abstract

Hidradenitis suppurativa (HS) is a chronic disease of the follicular unit that often leads to marked impairment of quality of life and usually affects the axillary, perineum and inframammary regions resulting in tender subcutaneous nodules, abscesses, fibrosis and sinus tract formation. New updates on HS underscores the role of various genes as well as the innate and adaptive immune response in its pathogenesis. Although every patient requires an individualized approach to treatment, topical therapy and antibiotics are mainly used for mild to moderate disease, whereas various systemic immune modulators and/or surgical approaches play a pivotal role in moderate to severe disease. New treatments using various immune modulators, laser modalities and other novel agents provide clinicians with better ways of managing HS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26382710

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN: 1201-5989


  2 in total

Review 1.  Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.

Authors:  Christina Fotiadou; Efstratios Vakirlis; Dimitrios Ioannides
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-10-19

2.  Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab.

Authors:  Dubravka Bosnić; Branimir Žarković; Marko Barešić; Maja Zarkovic; Branimir Anić
Journal:  Reumatologia       Date:  2016-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.